110 related articles for article (PubMed ID: 17673391)
1. Primary cutaneous CD8
Wei R; Wang H; Zhang J; Zhang Z; Yao Z
Int J Dermatol; 2024 May; 63(5):660-663. PubMed ID: 38263572
[No Abstract] [Full Text] [Related]
2. Panniculitic primary cutaneous gamma delta T-cell lymphoma with concomitant features of autoimmune disease emphasizing a pathophysiologic continuum of lupus profundus with the panniculitic T cell lymphomas.
Magro CM; Kalomeris T; Dillard A
Clin Dermatol; 2023; 41(6):680-691. PubMed ID: 37716581
[TBL] [Abstract][Full Text] [Related]
3. Probable Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma: A Case Report of a Diagnostic Challenge.
Velarde Loya M; Millan Reza MG; Olaya Cordova M; Chavéz López ZD
Cureus; 2023 Aug; 15(8):e44375. PubMed ID: 37654908
[TBL] [Abstract][Full Text] [Related]
4. The significance of epidermal involvement in primary cutaneous gamma/delta (γδ) T-cell lymphoma: A systematic review and meta-analysis.
Goyal A; O'Leary D; Duncan LM
J Cutan Pathol; 2021 Dec; 48(12):1449-1454. PubMed ID: 34151455
[TBL] [Abstract][Full Text] [Related]
5. Solitary CD8-Positive Primary Cutaneous Peripheral T-Cell Lymphoma: A Question of Classification.
Rolim I; BakShi A; West E; Azurdia R; Kempf W; Robson A
Am J Dermatopathol; 2021 Sep; 43(9):e107-e110. PubMed ID: 33767068
[TBL] [Abstract][Full Text] [Related]
6.
Blümel E; Munir Ahmad S; Nastasi C; Willerslev-Olsen A; Gluud M; Fredholm S; Hu T; Surewaard BGJ; Lindahl LM; Fogh H; Koralov SB; Rahbek Gjerdrum LM; Clark RA; Iversen L; Krejsgaard T; Bonefeld CM; Geisler C; Becker JC; Woetmann A; Andersen MH; Buus TB; Ødum N
Oncoimmunology; 2020; 9(1):1751561. PubMed ID: 32363124
[No Abstract] [Full Text] [Related]
7. Chronic Radiation Dermatitis Secondary to Narrow-Band Ultraviolet B Therapy in a Patient With Primary Cutaneous CD8 + T-Cell Lymphoma With Cytotoxic Granules.
Edelson MP; Gay JJ; Thiel RW; Grider DJ
Am J Dermatopathol; 2024 May; 46(5):312-315. PubMed ID: 38513130
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous acral CD8-positive T-cell lymphoproliferative disorder: A clinical and histologic retrospective cohort study.
Stephan C; Grossman ME; Magro CM
Clin Dermatol; 2023; 41(6):666-679. PubMed ID: 37716580
[TBL] [Abstract][Full Text] [Related]
9. Pillars Article: Regulation of Cutaneous Malignancy by γδ T Cells.
Girardi M; Oppenheim DE; Steele CR; Lewis JM; Glusac E; Filler R; Hobby P; Sutton B; Tigelaar RE; Hayday AC
J Immunol; 2018 May; 200(9):3031-3035. PubMed ID: 29685949
[No Abstract] [Full Text] [Related]
10. Aggressive CD8(+) epidermotropic cutaneous T-cell lymphoma associated with homozygous mutation in SAMHD1.
Merati M; Buethe DJ; Cooper KD; Honda KS; Wang H; Gerstenblith MR
JAAD Case Rep; 2015 Jul; 1(4):227-9. PubMed ID: 27051737
[No Abstract] [Full Text] [Related]
11. Lues maligna and HIV mimicking aggressive epidermotropic CD8+ cutaneous T-cell lymphoma.
Petrova E; Mateeva V; Kafelova A; Saleva-Stateva M; Radeva I; Yancheva N; Dikov T; Kazandjieva J; Miteva L; Dourmishev L
Indian J Dermatol Venereol Leprol; 2023 Jul; ():1-3. PubMed ID: 37609748
[No Abstract] [Full Text] [Related]
12. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
[TBL] [Abstract][Full Text] [Related]
13. Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas.
Barh D; Tiwari S; Gabriel Rodrigues Gomes L; Weener ME; Alzahrani KJ; Alsharif KF; Aljabali AAA; Tambuwala MM; Lundstrom K; Hassan SS; Serrano-Aroca Á; Takayama K; Ghosh P; Redwan EM; Silva Andrade B; Soares SC; Azevedo V; Uversky VN
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696358
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.
Yoshizawa N; Yagi H; Horibe T; Takigawa M; Sugiura M
Eur J Dermatol; 2007; 17(5):441-2. PubMed ID: 17673391
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
Gomez Vazquez M; Navarra Amayuelas R
Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
[TBL] [Abstract][Full Text] [Related]
17. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.
Introcaso CE; Kim EJ; Gardner J; Junkins-Hopkins JM; Vittorio CC; Rook AH
Arch Dermatol; 2008 Aug; 144(8):1027-9. PubMed ID: 18711076
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous CD8+ small/medium-sized pleomorphic T-cell lymphoma, ear-type: a unique cutaneous T-cell lymphoma with a favourable prognosis.
Géraud C; Goerdt S; Klemke CD
Br J Dermatol; 2011 Feb; 164(2):456-8. PubMed ID: 20969565
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
